Brief: Stoke Therapeutics Q2 revenue USD -2.481 million
07/08/2023 12:10
Aug 7 (Reuters) - Stoke Therapeutics Q2 operating expenses USD 30.781 million. * Q2 net income USD -30.654 million * Q2 operating income USD -33.262 million * Q2 basic EPS USD -0.69 * Q2 revenue USD -2.481 million vs. IBES estimate USD 3.44 million
Recent news on Stoke Therapeutics
See all newsBrief: Stoke Therapeutics Announces Inducement Grants
U.S. STOCKS ON THE MOVE-Moderna, O-I Glass, Aveanna Healthcare
U.S. STOCKS ON THE MOVE-NetEase, Werewolf Therapeutics, JP Morgan
U.S. STOCKS ON THE MOVE-Ubiquiti, BJ's Wholesale, Arbutus
U.S. STOCKS ON THE MOVE-Gold miners, Ross Stores, Stoke Therapeutics